Developer docs
API playgroundTry for free, no card

Search company profiles

Pro Doc Ltée

Full company profile

uuid000r9iz

Namestring
Pro Doc Ltée
Legal namestring
Pro Doc Ltée
Websiteurl
prodoc.qc.ca
Company typeenum
Private
Founded yearint
1955
Descriptiontext

Pro Doc Ltée is a Quebec-based, privately held generic pharmaceutical manufacturer that has been operating since 1955 and today employs 11-50 staff at its Laval, Quebec headquarters. The company produces approximately 300 prescription generic medications spanning cardiovascular (anticoagulants, statins, calcium channel blockers), central nervous system (anticonvulsants, neuropathic pain agents), anti-infectives (amoxicillin and combinations), antidiabetics (metformin), and gastrointestinal (proton pump inhibitors) therapeutic categories. Its products are bioequivalent to originator drugs, manufactured under Health Canada approval and rigorous quality controls on raw materials and finished products, and positioned as lower-cost alternatives enabled by the absence of medical-representation and large promotional spending.

Pro Doc generates revenue through one-time sales of these generic prescription products to community pharmacies across Quebec, distributing through its own field force of regional pharmaceutical representatives and an authenticated healthcare-professional portal that requires pharmacist or physician credentials for access. The company does not publicly disclose pricing; generic-pharmaceutical pricing is described as subject to government regulation and negotiated purchasing agreements. Distribution is structurally aligned with its corporate parent: Pro Doc has been a subsidiary of Groupe Jean Coutu since 2007 and is now part of METRO Inc.'s pharmacy division, alongside the Jean Coutu and Brunet retail pharmacy banners, providing captive shelf access across Quebec.

The business also operates supporting services including a pharmacovigilance/adverse-event reporting line with Health Canada regulatory escalation, bilingual (French/English) patient information leaflets, and a regional sales force covering every major Quebec administrative region. Pro Doc is not pursuing public listing, has no disclosed external funding, and serves the Canadian market only, with its website restricted to Canadian healthcare professionals. The combination of mature portfolio, parent-owned distribution, and Quebec-only footprint defines it as a stable, channel-anchored generic manufacturer rather than a growth-stage or technology-led business.

Short descriptiontext

Pro Doc Ltée is a Quebec-based generic pharmaceutical manufacturer (founded 1955) producing approximately 300 Health Canada-approved prescription generic drugs distributed to community pharmacies across Quebec. It is a wholly-owned subsidiary of METRO Inc., operating within its pharmacy division alongside the Jean Coutu and Brunet retail banners.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLaval, Canada
HQ citystring
Laval
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
generic pharmaceuticals, prescription medications, drug manufacturing, community pharmacy, pharmaceutical distribution
Industry3 codes
PRIMARYHLAIABAL
Generic Hospital & Institutional Products
SECONDARYHLAIAAAA
Primary Care & General Medicine Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIAAAB
Specialty Care Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
NAICS code2 codes
  • Pharmaceutical and Medicine Manufacturing3254
  • Pharmaceutical Preparation Manufacturing325412
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Generic Pharmaceuticals
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Generic Pharmaceutical Products
TypeOne Time License
Description

Pro Doc Ltée generates revenue through the sale of generic prescription medications to community pharmacies. The company offers nearly 300 generic drug products covering various therapeutic categories including cardiovascular, neurological, metabolic, and anti-infective medications. Generic drugs are sold at lower prices than original brand-name drugs while maintaining equivalent therapeutic efficacy.

prodoc.qc.ca
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales
Pricing details1 tier
1Generic pharmaceutical products distributed to community pharmacies
ModelOtherBilling cadenceOther
Notes

Pricing not publicly disclosed - pharmaceutical products typically subject to government regulation and negotiated through pharmacy purchasing agreements rather than public pricing.

prodoc.qc.ca
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Pro Doc Ltée manufactures and distributes nearly 300 generic prescription pharmaceutical products to community pharmacies, primarily in Quebec. The portfolio spans cardiovascular, neurological, metabolic, anti-infective, and gastrointestinal therapeutic categories, offering bioequivalent alternatives to brand-name medications at lower prices. Products are sold under both branded (PRO- prefixed) and unbranded generic formulations, with regulatory approval from Health Canada.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Generic drugs sold at lower prices than brand-name alternatives due to reduced spending on medical representation and advertising
+1 more record
Product overview1 text field

Pro Doc Ltée is a Quebec-based generic pharmaceutical manufacturer serving Canadian community pharmacies since 1955, now part of the METRO pharmacy division. The company offers approximately 300 generic prescription drug products, including cardiovascular medications (anticoagulants like apixaban, rivaroxaban, edoxaban; statins; calcium channel blockers; ACE inhibitors), CNS medications (anticonvulsants, antidepressants, antipsychotics), antibiotics (amoxicillin, fluoroquinolones), diabetes treatments (metformin, sitagliptin), and gastrointestinal drugs (proton pump inhibitors). Products are distributed through an authenticated healthcare professional portal and include patient-facing French and English information leaflets. The portfolio features branded variants prefixed with 'PRO-' alongside unbranded generic formulations.

Product and service4 records
1Generic Prescription Pharmaceutical Portfolio (~300 products)
CategoryGeneric Pharmaceutical Products
Description

A portfolio of nearly 300 generic prescription medications spanning therapeutic categories including antibiotics (amoxicillin, amoxicillin-clavulanate), cardiovascular agents (amlodipine, statins, anticoagulants such as apixaban, rivaroxaban, edoxaban), antidiabetics (metformin), neuropathic pain agents (pregabalin, gabapentin), and proton pump inhibitors (omeprazole, lansoprazole). Sold to community pharmacies as bioequivalent alternatives to brand-name drugs.

2Professional Healthcare Portal
CategoryB2B Healthcare Portal
Description

Authenticated web portal for Canadian healthcare professionals to access product information, requiring professional license verification, practice permit number, and provincial practice location.

3Consumer Information Leaflets (Feuillets d'informations)
CategoryPatient Education Resource
Description

PDF patient information leaflets for all Pro Doc generic medications, available in French and English, providing dosage, usage, and safety information for patients.

4Pharmacovigilance Services
CategoryAdverse Event Reporting Service
Description

Adverse drug reaction reporting system allowing healthcare professionals and consumers to report side effects, with regulatory reporting to Health Canada.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2007-01-01
Description

Pro Doc Ltée became a subsidiary of Groupe Jean Coutu in 2007. Groupe Jean Coutu is a major retail pharmacy chain in Quebec, making Pro Doc an integral part of their pharmaceutical distribution and generic drug supply strategy.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Pro Doc Ltée is now part of the METRO pharmacy division, which groups together the Jean Coutu and Brunet pharmacy brands. This integration under METRO Inc. provides expanded distribution channels and synergies across Quebec's pharmacy retail sector.

3Santé Canada (Health Canada)
TypeOthers
Description

Pro Doc Ltée products are subject to approval by Health Canada, which evaluates generic drugs for safety, efficacy, and quality. The evaluation process takes 2-5 years and ensures products meet the same standards as original medications.

prodoc.qc.ca
Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Laboratoire Riva is a Quebec-based privately-held Canadian generic pharmaceutical manufacturer, geographically and operationally similar to Pro Doc, serving community pharmacies with a comparable generic product portfolio.

TypeDirect peer
Description

Apotex is Canada's largest generic pharmaceutical manufacturer, producing a broad portfolio of generic prescription drugs. It is the most direct competitor to Pro Doc in the Canadian generic market, serving the same community pharmacy channel with overlapping therapeutic categories.

TypeDirect peer
Description

Pharmascience is a Montreal-based privately-held generic pharmaceutical manufacturer with a comparable portfolio of generic prescription products distributed to Canadian pharmacies. Geographic proximity (Quebec) and similar product breadth make it a close direct peer.

TypeDirect peer
Description

AA Pharma is a Canadian specialty generic pharmaceutical company that develops, manufactures, and markets generic prescription drugs. It is a direct peer competing in the Canadian community pharmacy channel.

TypeBroad incumbent
Description

Sandoz is the generic pharmaceuticals division of Novartis and a major player in the Canadian generic market. It competes with Pro Doc in generic prescription products distributed through community pharmacies, with a broader global portfolio.

TypeDirect peer
Description

Sanis Health is a Canadian-based generic pharmaceutical company offering a broad range of generic prescription medications. It serves the same community pharmacy channel and competes in overlapping therapeutic categories.

TypeDirect peer
Description

Directly comparable generic manufacturer competing on price and therapeutic breadth within the same community pharmacy channel.

TypeBroad incumbent
Description

Teva Canada is the Canadian arm of Teva Pharmaceutical Industries, one of the world's largest generic manufacturers. It competes with Pro Doc across multiple therapeutic categories in the Canadian generic prescription market and is a major incumbent in the same channel.

TypeBroad incumbent
Description

Viatris (formerly Mylan) is a global generics and specialty pharmaceutical company with a Canadian presence. It competes with Pro Doc in generic prescription categories distributed to community pharmacies across Canada.

TypeDirect peer
Description

Jamp Pharma is a Canadian generic pharmaceutical manufacturer offering a wide range of generic prescription products. It is a direct competitor in the Canadian community pharmacy channel, with a similar value proposition on price and quality.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Pro Doc Ltée

Generic Pharmaceuticalsprodoc.qc.ca

Pro Doc Ltée is a Quebec-based generic pharmaceutical manufacturer (founded 1955) producing approximately 300 Health Canada-approved prescription generic drugs distributed to community pharmacies across Quebec. It is a wholly-owned subsidiary of METRO Inc., operating within its pharmacy division alongside the Jean Coutu and Brunet retail banners.

What Pro Doc Ltée does

Pro Doc Ltée is a Quebec-based, privately held generic pharmaceutical manufacturer that has been operating since 1955 and today employs 11-50 staff at its Laval, Quebec headquarters. The company produces approximately 300 prescription generic medications spanning cardiovascular (anticoagulants, statins, calcium channel blockers), central nervous system (anticonvulsants, neuropathic pain agents), anti-infectives (amoxicillin and combinations), antidiabetics (metformin), and gastrointestinal (proton pump inhibitors) therapeutic categories. Its products are bioequivalent to originator drugs, manufactured under Health Canada approval and rigorous quality controls on raw materials and finished products, and positioned as lower-cost alternatives enabled by the absence of medical-representation and large promotional spending.

Pro Doc generates revenue through one-time sales of these generic prescription products to community pharmacies across Quebec, distributing through its own field force of regional pharmaceutical representatives and an authenticated healthcare-professional portal that requires pharmacist or physician credentials for access. The company does not publicly disclose pricing; generic-pharmaceutical pricing is described as subject to government regulation and negotiated purchasing agreements. Distribution is structurally aligned with its corporate parent: Pro Doc has been a subsidiary of Groupe Jean Coutu since 2007 and is now part of METRO Inc.'s pharmacy division, alongside the Jean Coutu and Brunet retail pharmacy banners, providing captive shelf access across Quebec.

The business also operates supporting services including a pharmacovigilance/adverse-event reporting line with Health Canada regulatory escalation, bilingual (French/English) patient information leaflets, and a regional sales force covering every major Quebec administrative region. Pro Doc is not pursuing public listing, has no disclosed external funding, and serves the Canadian market only, with its website restricted to Canadian healthcare professionals. The combination of mature portfolio, parent-owned distribution, and Quebec-only footprint defines it as a stable, channel-anchored generic manufacturer rather than a growth-stage or technology-led business.

Pro Doc Ltée firmographics

Firmographics
Name
Pro Doc Ltée
Legal name
Pro Doc Ltée
Website
https://prodoc.qc.ca
Company type
Private
Founded year
1955
Operating status
Operating
Headcount range
11–50 employees
Short description
Pro Doc Ltée is a Quebec-based generic pharmaceutical manufacturer (founded 1955) producing approximately 300 Health Canada-approved prescription generic drugs distributed to community pharmacies across Quebec. It is a wholly-owned subsidiary of METRO Inc., operating within its pharmacy division alongside the Jean Coutu and Brunet retail banners.
Ownership category
akta.pro rank

Pro Doc Ltée industry classification

Industry
Product category
Generic Pharmaceuticals
NAICS
Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical Preparation Manufacturing (325412)
SIC
Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAIABAL
Generic Hospital & Institutional Products
SECONDARYHLAIAAAA
Primary Care & General Medicine Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIAAAB
Specialty Care Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals

Keywords

  • Generic pharmaceuticals
  • Prescription medications
  • Drug manufacturing
  • Community pharmacy
  • Pharmaceutical distribution

Where Pro Doc Ltée is headquartered

Location

Headquarters

HQ city
Laval
HQ country
Canada
HQ region
North America

Offices1 record

Markets served

Pro Doc Ltée business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

  1. Generic Pharmaceutical Products: Pro Doc Ltée generates revenue through the sale of generic prescription medications to community pharmacies. The company offers nearly 300 generic drug products covering various therapeutic categories including cardiovascular, neurological, metabolic, and anti-infective medications. Generic drugs are sold at lower prices than original brand-name drugs while maintaining equivalent therapeutic efficacy.

Pricing tiers

ModelBillingPrice
OtherOtherGeneric pharmaceutical products distributed to community pharmacies

Go-to-market motion2 records

Distribution channels2 records

Marketing channels2 records

Pro Doc Ltée product offering

Product offering

Core offering

Pro Doc Ltée manufactures and distributes nearly 300 generic prescription pharmaceutical products to community pharmacies, primarily in Quebec. The portfolio spans cardiovascular, neurological, metabolic, anti-infective, and gastrointestinal therapeutic categories, offering bioequivalent alternatives to brand-name medications at lower prices. Products are sold under both branded (PRO- prefixed) and unbranded generic formulations, with regulatory approval from Health Canada.

Product overview

Pro Doc Ltée is a Quebec-based generic pharmaceutical manufacturer serving Canadian community pharmacies since 1955, now part of the METRO pharmacy division. The company offers approximately 300 generic prescription drug products, including cardiovascular medications (anticoagulants like apixaban, rivaroxaban, edoxaban; statins; calcium channel blockers; ACE inhibitors), CNS medications (anticonvulsants, antidepressants, antipsychotics), antibiotics (amoxicillin, fluoroquinolones), diabetes treatments (metformin, sitagliptin), and gastrointestinal drugs (proton pump inhibitors). Products are distributed through an authenticated healthcare professional portal and include patient-facing French and English information leaflets. The portfolio features branded variants prefixed with 'PRO-' alongside unbranded generic formulations.

Differentiator

Problem solved

Functional benefit

Products and services

  • Generic Prescription Pharmaceutical Portfolio (~300 products) A portfolio of nearly 300 generic prescription medications spanning therapeutic categories including antibiotics (amoxicillin, amoxicillin-clavulanate), cardiovascular agents (amlodipine, statins, anticoagulants such as apixaban, rivaroxaban, edoxaban), antidiabetics (metformin), neuropathic pain agents (pregabalin, gabapentin), and proton pump inhibitors (omeprazole, lansoprazole). Sold to community pharmacies as bioequivalent alternatives to brand-name drugs.
  • Professional Healthcare Portal Authenticated web portal for Canadian healthcare professionals to access product information, requiring professional license verification, practice permit number, and provincial practice location.
  • Consumer Information Leaflets (Feuillets d'informations) PDF patient information leaflets for all Pro Doc generic medications, available in French and English, providing dosage, usage, and safety information for patients.
  • Pharmacovigilance Services Adverse drug reaction reporting system allowing healthcare professionals and consumers to report side effects, with regulatory reporting to Health Canada.

Quantifiable outcome

  • Generic drugs sold at lower prices than brand-name alternatives due to reduced spending on medical representation and advertising
  • +1 more outcomes

Companies that use Pro Doc Ltée

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Pro Doc Ltée technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Pro Doc Ltée partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • Groupe Jean Coutu (PJC) inc.coreStrategic or Co-development Partner · 1 January 2007Pro Doc Ltée became a subsidiary of Groupe Jean Coutu in 2007. Groupe Jean Coutu is a major retail pharmacy chain in Quebec, making Pro Doc an integral part of their pharmaceutical distribution and generic drug supply strategy.
  • METRO Inc. (Pharmacy Division)coreStrategic or Co-development PartnerPro Doc Ltée is now part of the METRO pharmacy division, which groups together the Jean Coutu and Brunet pharmacy brands. This integration under METRO Inc. provides expanded distribution channels and synergies across Quebec's pharmacy retail sector.
  • Santé Canada (Health Canada)OthersPro Doc Ltée products are subject to approval by Health Canada, which evaluates generic drugs for safety, efficacy, and quality. The evaluation process takes 2-5 years and ensures products meet the same standards as original medications.

Scale indicators3 records

Recent moves8 records

Expansion highlights5 records

Pro Doc Ltée competitors and assessment

Company assessment

Direct peers

  • Laboratoire Riva: Laboratoire Riva is a Quebec-based privately-held Canadian generic pharmaceutical manufacturer, geographically and operationally similar to Pro Doc, serving community pharmacies with a comparable generic product portfolio.
  • Apotex Inc. Apotex is Canada's largest generic pharmaceutical manufacturer, producing a broad portfolio of generic prescription drugs. It is the most direct competitor to Pro Doc in the Canadian generic market, serving the same community pharmacy channel with overlapping therapeutic categories.
  • Pharmascience Inc. Pharmascience is a Montreal-based privately-held generic pharmaceutical manufacturer with a comparable portfolio of generic prescription products distributed to Canadian pharmacies. Geographic proximity (Quebec) and similar product breadth make it a close direct peer.
  • AA Pharma: AA Pharma is a Canadian specialty generic pharmaceutical company that develops, manufactures, and markets generic prescription drugs. It is a direct peer competing in the Canadian community pharmacy channel.
  • Sanis Health: Sanis Health is a Canadian-based generic pharmaceutical company offering a broad range of generic prescription medications. It serves the same community pharmacy channel and competes in overlapping therapeutic categories.
  • Apotex — focused on retail generics in Canada: Directly comparable generic manufacturer competing on price and therapeutic breadth within the same community pharmacy channel.
  • Jamp Pharma: Jamp Pharma is a Canadian generic pharmaceutical manufacturer offering a wide range of generic prescription products. It is a direct competitor in the Canadian community pharmacy channel, with a similar value proposition on price and quality.

Broad incumbents

  • Sandoz Canada: Sandoz is the generic pharmaceuticals division of Novartis and a major player in the Canadian generic market. It competes with Pro Doc in generic prescription products distributed through community pharmacies, with a broader global portfolio.
  • Teva Canada: Teva Canada is the Canadian arm of Teva Pharmaceutical Industries, one of the world's largest generic manufacturers. It competes with Pro Doc across multiple therapeutic categories in the Canadian generic prescription market and is a major incumbent in the same channel.
  • Mylan Pharmaceuticals ULC (Viatris): Viatris (formerly Mylan) is a global generics and specialty pharmaceutical company with a Canadian presence. It competes with Pro Doc in generic prescription categories distributed to community pharmacies across Canada.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Pro Doc Ltée social profiles

Digital presence

Pro Doc Ltée financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Pro Doc Ltée leadership team

Management profile

Number of profiles

Profiles8 records

Pro Doc Ltée funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Pro Doc Ltée M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pro Doc Ltée

What does Pro Doc Ltée do?

Pro Doc Ltée manufactures and distributes nearly 300 generic prescription pharmaceutical products to community pharmacies, primarily in Quebec. The portfolio spans cardiovascular, neurological, metabolic, anti-infective, and gastrointestinal therapeutic categories, offering bioequivalent alternatives to brand-name medications at lower prices. Products are sold under both branded (PRO- prefixed) and unbranded generic formulations, with regulatory approval from Health Canada.

Is Pro Doc Ltée a public or private company?

Pro Doc Ltée is a private company. It is classified as corporate owned and is currently operating.

When was Pro Doc Ltée founded?

Pro Doc Ltée was founded in 1955. It employs 11 to 50 people.

Where is Pro Doc Ltée based?

Pro Doc Ltée is headquartered in Laval, Canada, in the North America region.

How does Pro Doc Ltée make money?

One revenue line is on record: generic Pharmaceutical Products.

Who are Pro Doc Ltée's main competitors?

Direct peers on record are Laboratoire Riva, Apotex Inc., Pharmascience Inc., AA Pharma, Sanis Health, Apotex — focused on retail generics in Canada and Jamp Pharma. Broad incumbents are Sandoz Canada, Teva Canada and Mylan Pharmaceuticals ULC (Viatris).

Does Pro Doc Ltée have an API?

No public API is recorded for Pro Doc Ltée.

What industry is Pro Doc Ltée in?

Pro Doc Ltée's product category is Generic Pharmaceuticals. Its primary akta.pro industry code is HLAIABAL, Generic Hospital & Institutional Products, with a secondary code of HLAIAAAA, Primary Care & General Medicine Pharmaceuticals. Its NAICS code is 3254 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales